SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally 
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026 
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure 
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid 
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 
NEW YORK, March 17, 2017 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Texas, Tyler Division on behalf of investors who purchased Adeptus Health Inc. ("Adeptus Health Inc.") (NYSE:ADPT) securities between April 29, 2016 and March 1, 2017.
Click here to learn about the case: http://www.wongesq.com/pslra-sa/adeptus-health-inc. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (1) Adeptus had material weaknesses in its internal control over financial reporting in the areas of revenue recognition, accounts receivable, accounting for a contribution to an unconsolidated joint venture, and accounting for equity in (loss) earnings of unconsolidated joint ventures; and (2) as a result, defendants’ statements about Adeptus’ business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you suffered a loss in Adeptus Health Inc. you have until May 9, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-sa/adeptus-health-inc.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]
